Skip navigation.
Fri Feb 12 17:55:10 2010 [Write for us] | [Login/Register]
Home

Study targets histone proteins

user warning: Duplicate entry '985101' for key 1 query: INSERT INTO accesslog (title, path, url, hostname, uid, sid, timer, timestamp) values('Scientists struggle for mercury answers', 'node/88697', 'http://themoneytimes.com/channels/technology/science_medicine?page=8', '207.241.228.148', 0, '9efa52b375c4e67dc259374ecaa1bb16', 258, 1266015268) in /home/themoney/public_html/modules/statistics/statistics.module on line 64.

Oklahoma -- A team of U.S. scientists says it has discovered an antibody that could counter proteins called histones, which often cause uncontrolled internal bleeding.

The Oklahoma Medical Research Foundation scientists said their finding could help save lives threatened by traumatic injuries and also holds potential for treating severe infectious diseases and diabetes.

Led by researcher Charles Esmon, the scientists said their study has cast new light on how histones enter the bloodstream and begin to kill the lining of blood vessels. Building on that discovery, Esmon and his colleagues identified an antibody that could counter that process.

"This discovery could open the door to new ways to treat soldiers hurt in IED (improved explosive device) attacks, gunshot wound victims and people who suffer a traumatic injury," said Esmon.

Working Dr. Marc Monestier of Temple University, the group discovered antibodies that can block the histones' ability to kill.

"When a patient is suffering from severe bleeds, these antibodies could prevent multi-organ failure," Esmon said.

The researchers have already tested the antibodies in pre-clinical trials, in which they showed promising results and no adverse effects. A potential future step, Esmon said, would be human trials.

The study that included Florea Lupu and Jun Xu appears in the early online edition of the journal Nature Medicine.

Copyright 2009 by United Press International.

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Recent comments

The Money Times on Facebook

User login